US pharmaceutical major Johnson and Johnson has joined hands with Biological E Limited - Telangana-based pharma company - for the manufacturing of the COVID-19 vaccine, as per an official statement on Tuesday.

Notably, the vaccine named, Janssen Covid-19 vaccine is currently approved in United States, Europe and other nations including Thailand and South Africa.

An official statement by Johnson and Johnson reads, “Johnson & Johnson is working with Biological E. Limited on the manufacturing of the Johnson COVID-19 vaccine. We believe Biological E. will be an important part of our global COVID-19 vaccine supply network, where multiple manufacturing sites are involved in the production of our vaccine across different facilities, sometimes in different countries and continents, before the vaccine can be distributed,"

The statement from Johnson and Johnson also said that the company is working around the clock to develop and broadly activate our manufacturing capabilities to supply our COVID-19 vaccine worldwide. “We appreciate the ongoing and extensive collaborations and partnerships we have with governments, health authorities and other companies to help end this pandemic", Johnson and Johnson stated.” 

India is second largest insurance-technology market in Asia Pacific: S&P Global Report

Indian Economy will improve after a critical mass is vaccinated: Ashima Goyal

Tamil Nadu government releases details of CM relief fund inflows, expenses